Vigil Announces Upcoming Presentations at 2024 American Academy of Neurology Annual Meeting
WATERTOWN, Mass., March 13, 2024 -- Vigil Neuroscience, Inc. , a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases,...
Source: marketscreener.com